Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype
Viruses · 2025
DOI: 10.3390/v17040544 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Shuxia Zhang und 14 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, …. Hauptthemen laut MEDLINE: Influenza Vaccines, Influenza A Virus, H5N8 Subtype, Orthomyxoviridae Infections. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Key Research and Development Program of China, National Key Research and Development Program of China, National Public Health Talents Program of Cultivation and Support.
Abstract (Originalsprache)
Multiple subtypes of avian influenza virus (AIV), including H5N1, H5N6, and H5N8 viruses, are currently co-circulating in wild birds and poultry and causing sporadic human infections. Vaccine development is essential for pandemic preparedness. In this study, we constructed a candidate vaccine virus (CVV) using reverse genetics (RG) based on the sequence of the first human-infected H5N8 subtype AIV, A/Astrakhan/3212/2020 (H5N8). We evaluated the immunogenicity of the rH5N8/PR8 vaccine strain in combination with Alum, ISA51, and MF59 adjuvants, and we optimized immunization strategies including dosage, administration route, and immunization interval in BALB/c mice. Our results demonstrated that a 10 μg dose of inactivated rH5N8/PR8 with MF59 adjuvant, administered intramuscularly twice at 7-day intervals, induced the strongest immune response and effectively protected mice against challenge with wild-type H5N8 AIVs. Since pandemic influenza vaccines typically require tailored vaccination doses and routes specific to their characteristics, this study provides valuable insights for the development of similar vaccine strains with pandemic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, Chi…
ORCID-Profile: Shuxia Zhang, Dayan Wang
Förderung
- the National Key Research and Development Program of China
- National Key Research and Development Program of China
- National Public Health Talents Program of Cultivation and Support
Zitieren
APA
Zhang, S., Tang, J., Liu, L., Wei, H., Xin, L., Xiao, K., Xiao, J., Dong, J., Li, Z., Bai, H., Wang, S., Zhu, W., Yang, L., Zou, S., & Wang, D. (2025). Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype. Viruses. https://doi.org/10.3390/v17040544
Vancouver
Zhang S, Tang J, Liu L, Wei H, Xin L, Xiao K, et al. Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype. Viruses. 2025. doi:10.3390/v17040544
BibTeX
@article{Zhang2025,
author = {Zhang, Shuxia and Tang, Jing and Liu, Liqi and Wei, Hejiang and Xin, Li and Xiao, Kang and Xiao, Jinbo and Dong, Jie and Li, Zi and Bai, Hongyan and Wang, Shuaixing and Zhu, Wenfei and Yang, Lei and Zou, Shumei and Wang, Dayan},
title = {Construction and Immune Strategy Optimization of a Vaccine Strain for Influenza A (H5N8) Subtype},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17040544}
}
EUVIMED